Julie Grant co-founded and served as founding CEO of Day One Biopharmaceuticals at Canaan Partners, taking an unusually hands-on operator role for a venture investor by building the company around pediatric oncology and challenging the industry norm of prioritizing adult cancers over children. She functions as an incubator of life science startups within Canaan, founding multiple companies and advancing rapidly from associate to general partner while combining her scientific background with policy influence through roles like her appointment to the National Cancer Advisory Board. Julie Grant co-founded and served as founding CEO of Day One Biopharmaceuticals at Canaan Partners, taking an unusually hands-on operator role for a venture investor by building the company around pediatric oncology and challenging the industry norm of prioritizing adult cancers over children. She functions as an incubator of life science startups within Canaan, founding multiple companies and advancing rapidly from associate to general partner while combining her scientific background with policy influence through roles like her appointment to the National Cancer Advisory Board.